Anticancer properties of novel aminoacetonitrile derivative monepantel (ADD 1566) in pre-clinical models of human ovarian cancer.
Saved in:
| Title: | Anticancer properties of novel aminoacetonitrile derivative monepantel (ADD 1566) in pre-clinical models of human ovarian cancer. |
|---|---|
| Authors: | Bahrami F; Department of Surgery, Cancer Research Laboratory, University of New South Wales, St George Hospital Sydney, New South Wales 2217, Australia., Morris DL; Department of Surgery, Cancer Research Laboratory, University of New South Wales, St George Hospital Sydney, New South Wales 2217, Australia., Rufener L; Novartis Centre de Recherche Santé Animale CH-1566 St Aubin (FR), Switzerland., Pourgholami MH; Department of Surgery, Cancer Research Laboratory, St George Hospital Sydney, New South Wales 2217, Australia. |
| Source: | American journal of cancer research [Am J Cancer Res] 2014 Sep 06; Vol. 4 (5), pp. 545-57. Date of Electronic Publication: 2014 Sep 06 (Print Publication: 2014). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: e-Century Pub. Corp Country of Publication: United States NLM ID: 101549944 Publication Model: eCollection Cited Medium: Print ISSN: 2156-6976 (Print) Linking ISSN: 21566976 NLM ISO Abbreviation: Am J Cancer Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
